Regional reporting of adverse drug reactions:: A new computer-based network

被引:0
|
作者
Swoboda, WJ [1 ]
Göttler, M
Hasford, J
机构
[1] Univ Munich, Dept Neurol, D-80539 Munich, Germany
[2] Univ Munich, Dept Med Informat Biometry & Epidemiol, Pharmacoepidemiol Res Grp, Munich, Germany
关键词
adverse drug reaction (ADR); adverse event (AE); reporting; network; EUROSCAPE; EDIFACT; ICH; data security; digital signature;
D O I
10.1002/(SICI)1099-1557(199904)8:1+<S47::AID-PDS408>3.3.CO;2-C
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The use of drugs is always accompanied by the risk of adverse drug reactions (ADRs) and adverse events (AE). Generally physicians, pharmaceutical manufacturers, and pharmacists use a paper-based form for sending spontaneous ADR and AE reports to the national drug regulatory authority. Besides under-reporting, reporting lag-time and errors through data transformation are a major issue. In order to improve the current reporting situation we have set up a new computer-based, network-driven system for storing, transferring, and evaluating ADR reports. The system consists of three regional centres, one coordinating centre, and the central ADR database of the national drug regulatory authority. In the regional centres, clinical pharmacologists collect ADR data in local databases. There is a comfortable user-interface with an online help-function available. New reports are sent automatically to the Federal Agency using EUROSCAPE as a standardized electronic report form of the EU. The coordinating centre in Munich is responsible for overall performance and quality assurance. This model for a clinical health information network is of a high level of data security, is reliable and easily expandable through the use of standard tools, is fast and also inexpensive by using standard shareware products. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:S47 / S53
页数:7
相关论文
共 50 条
  • [31] Online Reporting of Adverse Drug Reactions: A Study from a French Regional Pharmacovigilance Center
    Abadie, Delphine
    Chebane, Leyla
    Bert, Max
    Durrieu, Genevieve
    Montastruc, Jean-Louis
    THERAPIE, 2014, 69 (05): : 395 - 400
  • [32] THE NEW COMPUTER-BASED ANIMAL-DISEASE REPORTING SYSTEM IN GERMANY
    MICKLICH, A
    KROSCHEWSKI, K
    SCHRODER, R
    KLOSS, D
    TIERARZTLICHE UMSCHAU, 1994, 49 (09): : 589 - 593
  • [33] Evolution of adverse drug reactions reporting systems: paper based to software based
    M. T. Madhushika
    T. P. Weerarathna
    P. L. G. C. Liyanage
    S. S. Jayasinghe
    European Journal of Clinical Pharmacology, 2022, 78 : 1385 - 1390
  • [34] Evolution of adverse drug reactions reporting systems: paper based to software based
    Madhushika, M. T.
    Weerarathna, T. P.
    Liyanage, P. L. G. C.
    Jayasinghe, S. S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (09) : 1385 - 1390
  • [35] Reporting Adverse Drug Reactions in Product Labels
    Brenda Crowe
    Christy Chuang-Stein
    Sally Lettis
    Andreas Brueckner
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 455 - 463
  • [36] MONITORING AND REPORTING ADVERSE DRUG-REACTIONS
    SMITH, MA
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (01): : 65 - 66
  • [37] STANDARDS FOR REPORTING ADVERSE DRUG-REACTIONS
    BERNEKER, GC
    BRITISH MEDICAL JOURNAL, 1984, 288 (6420): : 865 - 865
  • [38] REPORTING RATES OF ADVERSE DRUG-REACTIONS
    RICH, DS
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (13): : 1710 - 1711
  • [39] BETTER REPORTING OF ADVERSE DRUG-REACTIONS
    ABRUTYN, E
    ANNALS OF INTERNAL MEDICINE, 1985, 102 (02) : 264 - 265
  • [40] A novel scheme for the reporting of adverse drug reactions
    Clarkson, A
    Ingleby, E
    Choonara, I
    Bryan, P
    Arlett, P
    ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 84 (04) : 337 - 339